These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 32043370
1. Prostaglandin analogues: A double-edged sword in orbital glaucoma disease management. Joganathan V, Cannon PS, Mercieca K. Eur J Ophthalmol; 2021 May; 31(3):NP40-NP44. PubMed ID: 32043370 [Abstract] [Full Text] [Related]
2. Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues. El Ameen A, Vandermeer G, Khanna RK, Pisella PJ. Eur J Ophthalmol; 2019 Nov; 29(6):645-653. PubMed ID: 30301370 [Abstract] [Full Text] [Related]
3. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma. Kim JS, Blizzard S, Woodward JA, Leyngold IM, Liss J, Freedman SF. Ophthalmol Glaucoma; 2020 Nov; 3(4):288-294. PubMed ID: 33008561 [Abstract] [Full Text] [Related]
5. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost. Kucukevcilioglu M, Bayer A, Uysal Y, Altinsoy HI. Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550 [Abstract] [Full Text] [Related]
6. Clinical Staging of Prostaglandin-Associated Periorbitopathy Syndrome in Glaucoma: A Review from Asia. Liu C, Wong T, Leung D, Park HL, Aung T, Aihara M, Makornwattana M, Fang SK, Park KH, Leung C. Semin Ophthalmol; 2024 Aug; 39(6):424-428. PubMed ID: 38842062 [Abstract] [Full Text] [Related]
7. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment. Stjernschantz J, Selén G, Astin M, Resul B. Prog Retin Eye Res; 2000 Jul; 19(4):459-96. PubMed ID: 10785618 [Abstract] [Full Text] [Related]
12. A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension. Hommer A. Drugs Today (Barc); 2010 Jun; 46(6):409-16. PubMed ID: 20571609 [Abstract] [Full Text] [Related]
13. Oculoplastic considerations in patients with glaucoma. Tan P, Malhotra R. Surv Ophthalmol; 2016 Jun; 61(6):718-725. PubMed ID: 27045224 [Abstract] [Full Text] [Related]
15. Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis. Harasymowycz P, Hutnik C, Rouland JF, Negrete FJM, Economou MA, Denis P, Baudouin C. Adv Ther; 2021 Jun; 38(6):3019-3031. PubMed ID: 33891269 [Abstract] [Full Text] [Related]
18. Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases. Schwartz GF, Kotak S, Mardekian J, Fain JM. BMC Ophthalmol; 2011 Jun 14; 11():14. PubMed ID: 21672240 [Abstract] [Full Text] [Related]
19. Adverse periocular reactions to five types of prostaglandin analogs. Inoue K, Shiokawa M, Higa R, Sugahara M, Soga T, Wakakura M, Tomita G. Eye (Lond); 2012 Nov 14; 26(11):1465-72. PubMed ID: 23037910 [Abstract] [Full Text] [Related]
20. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension. Lin L, Zhao YJ, Chew PT, Sng CC, Wong HT, Yip LW, Wu TS, Bautista D, Teng M, Khoo AL, Lim BP. Ann Pharmacother; 2014 Dec 14; 48(12):1585-93. PubMed ID: 25184309 [Abstract] [Full Text] [Related] Page: [Next] [New Search]